×
About 29,982 results

ALLMedicine™ Atopic Dermatitis Center

Research & Reviews  13,277 results

Association of Wildfire Air Pollution and Health Care Use for Atopic Dermatitis and Itch.
https://doi.org/10.1001/jamadermatol.2021.0179
JAMA Dermatology; Fadadu RP, Grimes B et. al.

Apr 21st, 2021 - Air pollution is a worldwide public health issue that has been exacerbated by recent wildfires, but the relationship between wildfire-associated air pollution and inflammatory skin diseases is unknown. To assess the associations between wildfire-a...

Human leukocyte antigen class-I variation is associated with atopic dermatitis: A case-...
https://doi.org/10.1016/j.humimm.2021.04.001
Human Immunology; Margolis DJ, Mitra N et. al.

Apr 20th, 2021 - Atopic dermatitis (AD) is a common immune-medicated skin disease. Previous studies have explored the relationship between Human Leukocyte Antigen (HLA) allelic variation and AD with conflicting results. The aim was to examine HLA Class I genetic v...

Efficacy and safety of Chinese herbal medicine Jianpi formulas for atopic dermatitis: E...
https://doi.org/10.1111/jocd.14165
Journal of Cosmetic Dermatology; Li H, Sun X et. al.

Apr 20th, 2021 - Jianpi formulas have been widely used to treat atopic dermatitis (AD) by traditional Chinese medicine (TCM) practitioners, but the efficacy and safety need further evaluation. A meta-analysis of randomized controlled trials was performed to assess...

Can we safely use systemic treatment in atopic dermatitis during the COVID-19 pandemic?...
https://doi.org/10.1080/1744666X.2021.1919511
Expert Review of Clinical Immunology; Marko M, Pawliczak R

Apr 19th, 2021 - Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, the medical community has faced major challenges that affect disease management in all areas. Dermatologists and immunologists have to choose appropriate treatment strategy takin...

Drug survival rates and reasons for drug discontinuation in patients with atopic dermat...
https://doi.org/10.1684/ejd.2021.4020
European Journal of Dermatology : EJD; Pino Lopez J, Kromer C et. al.

Apr 19th, 2021 - Treatment of moderate-to-severe atopic dermatitis (AD) can be challenging and little is known about the sustainability of on- and off-label prescribed systemic therapies. To compare drug survival (DS) rates and reasons for drug discontinuation of ...

see more →

Guidelines  35 results

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis...
https://www.ncbi.nlm.nih.gov/pubmed/33147660
Dermatology Online Journal; Yim RM, Singh I et. al.

Nov 4th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

Atopic dermatitis/Eczema | DermNet NZ
https://www.dermnetnz.org/topics/atopic-dermatitis/

Jun 24th, 2019 - Atopic dermatitis is a chronic, itchy skin condition that is very common in children but may occur at any age. It is also known as eczema and atopic eczema and was formerly known as Besnier prurigo. It is the most common form of dermatitis. Atopi...

European task force on atopic dermatitis position paper: treatment of parental atopic d...
https://doi.org/10.1111/jdv.15709
Journal of the European Academy of Dermatology and Venere... Vestergaard C, Wollenberg A et. al.

Jun 24th, 2019 - Atopic dermatitis (AD) is a common inflammatory skin disease that affects both children and adults, including a large number of adults of reproductive age. Several guidelines for the treatment of AD exist, yet specific recommendations for the trea...

Eczema - StatPearls
https://www.ncbi.nlm.nih.gov/books/NBK538209/
Nemeth,V.,et al

Jun 3rd, 2019 - Eczema, also known as atopic dermatitis, is the most common form of dermatitis. Genetic as well as environmental factors are thought to play a part in the pathogenesis. Eczema is most commonly seen in children but can be seen in adults. People ...

The Effects of Early Nutritional Interventions on the Development of Atopic Disease in Infants and Children: The Role of Maternal Dietary Restriction, Breastfeeding, Hydrolyzed Formulas, and Timing...
https://doi.org/10.1542/peds.2019-0281

Mar 17th, 2019 - This clinical report updates and replaces a 2008 clinical report from the American Academy of Pediatrics, which addressed the roles of maternal and early infant diet on the prevention of atopic disease, including atopic dermatitis, asthma, and foo...

see more →

Drugs  633 results see all →

Clinicaltrials.gov  14,501 results

Association of Wildfire Air Pollution and Health Care Use for Atopic Dermatitis and Itch.
https://doi.org/10.1001/jamadermatol.2021.0179
JAMA Dermatology; Fadadu RP, Grimes B et. al.

Apr 21st, 2021 - Air pollution is a worldwide public health issue that has been exacerbated by recent wildfires, but the relationship between wildfire-associated air pollution and inflammatory skin diseases is unknown. To assess the associations between wildfire-a...

Human leukocyte antigen class-I variation is associated with atopic dermatitis: A case-...
https://doi.org/10.1016/j.humimm.2021.04.001
Human Immunology; Margolis DJ, Mitra N et. al.

Apr 20th, 2021 - Atopic dermatitis (AD) is a common immune-medicated skin disease. Previous studies have explored the relationship between Human Leukocyte Antigen (HLA) allelic variation and AD with conflicting results. The aim was to examine HLA Class I genetic v...

Efficacy and safety of Chinese herbal medicine Jianpi formulas for atopic dermatitis: E...
https://doi.org/10.1111/jocd.14165
Journal of Cosmetic Dermatology; Li H, Sun X et. al.

Apr 20th, 2021 - Jianpi formulas have been widely used to treat atopic dermatitis (AD) by traditional Chinese medicine (TCM) practitioners, but the efficacy and safety need further evaluation. A meta-analysis of randomized controlled trials was performed to assess...

Can we safely use systemic treatment in atopic dermatitis during the COVID-19 pandemic?...
https://doi.org/10.1080/1744666X.2021.1919511
Expert Review of Clinical Immunology; Marko M, Pawliczak R

Apr 19th, 2021 - Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, the medical community has faced major challenges that affect disease management in all areas. Dermatologists and immunologists have to choose appropriate treatment strategy takin...

Drug survival rates and reasons for drug discontinuation in patients with atopic dermat...
https://doi.org/10.1684/ejd.2021.4020
European Journal of Dermatology : EJD; Pino Lopez J, Kromer C et. al.

Apr 19th, 2021 - Treatment of moderate-to-severe atopic dermatitis (AD) can be challenging and little is known about the sustainability of on- and off-label prescribed systemic therapies. To compare drug survival (DS) rates and reasons for drug discontinuation of ...

see more →

News  1,511 results

Atopic Dermatitis Linked to Learning Disability, Educational Achievement
https://www.medscape.com/viewarticle/949564

Apr 19th, 2021 - NEW YORK (Reuters Health) – Two registry studies point to connections between atopic dermatitis (AD) and learning problems and possible lower educational attainment in young people. Both studies were published in JAMA Dermatology. In the first stu...

Study Enhances Understanding of 'Tremendously Understudied' Prurigo Nodularis
https://www.medscape.com/viewarticle/949495

Apr 18th, 2021 - Patients with prurigo nodularis tend to make a greater number of visits to health care specialists and are burdened by a greater number of medical comorbidities, compared with age-matched controls, as well those with atopic dermatitis and psoriasi...

AAP Issues Recommendations for Common Dermatologic Problems
https://www.medscape.com/viewarticle/949207

Apr 12th, 2021 - The American Academy of Pediatrics recently issued five recommendations for the most common dermatologic problems in primary care pediatrics. Topics include diagnostic and management strategies for a variety of conditions, including atopic dermati...

US FDA Extends Review of Pfizer's Experimental Skin Disease Drug
https://www.medscape.com/viewarticle/948892

Apr 7th, 2021 - (Reuters) - Pfizer Inc said on Wednesday the U.S. Food and Drug Administration (FDA) had extended the review of its experimental atopic dermatitis drug by three months, the latest regulatory setback for a class of treatments known as JAK inhibitor...

Itch Response Faster With Abrocitinib in Trial Comparing JAK Inhibitor to Dupilumab
https://www.medscape.com/viewarticle/948150

Mar 24th, 2021 - An experimental oral Janus kinase 1 (JAK1) inhibitor, abrocitinib, showed greater itch reduction after 2 weeks of treatment than dupilumab in patients with moderate to severe atopic dermatitis (AD), in a multicenter, randomized trial. An experimen...

see more →

Patient Education  25 results see all →